|
|
|
| Advocacy > Federal > Regulatory > Practice issues > Vaccines > Canine influenza |
|
| |
Federal regulatory practice issues: Vaccines
|
| The need for effective canine influenza virus vaccine |
|
|
| Brief Description |
| Canine influenza virus (CIV) is a newly emerging pathogen which is highly contagious, reaching infection rates of over 90% following exposure. CIV is associated with low mortality rates; however hundreds of dogs have already died as a direct result of depopulation of animal shelters to control outbreaks. It has also led to financial losses of over $5 million for the racing industry, boarding kennels, veterinary practices, and animal shelters since 2004.
The AVMA believes that the issue of Canine Influenza and the lack of a vaccine is so important the organization brought it to the attention of the USDA, encouraging approval of a safe and effective vaccine. |
| Full AVMA Letter: |
| View AVMA's letter to USDA (PDF) (November 21, 2006) |
| View AVMA's second letter to USDA (PDF) (March 28, 2008) |
| Status |
| AVMA sent a letter on November 21, 2006 and March 28, 2008. |
|
|
| |
| | |
| | |
American Veterinary Medical Association
|
|
= AVMA/SAVMA Members Only
